Manvendra Kumar
5PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 06, 2026
Synthesis of New Substituted 5H-Benzo[e]imidazo[1,2-a][1,4]diazepines via Pictet-Spengler Reaction and Their Neuroprotective and Anticonvulsant Evaluation.Manvendra Kumar, Shubham Upadhayay, Pritam Maity
|Jan 14, 2025
Design and Synthesis of Topoisomerases-Histone Deacetylase Dual Targeted Quinoline-Bridged Hydroxamates as Anticancer Agents.Gaurav Joshi, Umesh Prasad Yadav, Zahid Rafiq
|Jul 19, 2024
Design, synthesis, and anticancer assessment of structural analogues of (E)-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]quinoxaline-2-carbonitrile (6b), an imidazo[1,2-a]quinoxaline-based non-covalent EGFR inhibitor.Manvendra Kumar, Kiran T Patil, Pritam Maity
|Feb 22, 2023
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities.Pritam Maity, Joydeep Chatterjee, Kiran T Patil
|Sep 09, 2022
In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice.Zahid Rafiq Bhat, Manvendra Kumar, Nisha Sharma
Pageof 1
